Dr. Killelea talks about the importance of communication between all healthcare providers when treating patients with breast cancer.
The Leukemia & Lymphoma Society asked Ann McNeill, a registered nurse who has worked with cancer patients for 12 years, to share five healthy tips she and her colleagues often stress to patients.
Radiation's role continues to shift in the treatment of patients with prostate cancer.
Richard Essner, MD, co-director Melanoma Program, Cedars-Sinai Medical Center, discusses the nurse’s role in managing wounds after a patient undergoes surgery for melanoma.
Chemotherapy is often associated with devastating toxicities, but moxetumomab pasudotox appears to be manageable based on the findings from a new trial.
Ã…ge Schultz, DVM, PhD, executive director, Multinational Association of Supportive Care in Cancer (MASCC), explains the importance of the MASCC/ISOO International Symposium on Supportive Care in Cancer for an oncology nurse.
Though having well-fitting wigs and prostheses may seem like secondary concerns to some, providing these items—and a safe environment within which to learn about them—can go a long way in helping a patient feel supported and positive about their appearance while they are receiving treatment.
Jennifer Montes, MD, New York University Medical Center, discusses the role of nurses in treating patients with breast cancer.
Elizabeth Cruz, RN, Memorial Sloan Kettering Cancer Center, discusses differentiating symptoms of neuroendocrine tumors (NETs) from secondary conditions.
Ten years after founding The Julie Fund for Women's Cancers, President Peter McAvinn's resolve is stronger than ever.
Patients with neuroendocrine tumors have seen a slew of new treatment options, but experts believe these options need much more study before their promise is fully realized.
Celebration at the end of cancer treatment is often premature.
Anees B. Chagpar, MD, MSc, MA, MPH, discusses the role of nurses in the decision making process for breast cancer care.
While many oral therapies are used to treat multiple myeloma, nonadherence to oral anticancer agents continues to be a challenge.
Up to 40% of patients with cancer who take opioids experience nausea and vomiting.
C. Ola Landgren, MD, PhD, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses treating smoldering multiple myeloma.
Patients with biochemically recurrent nonmetastatic hormone-sensitive prostate cancer who are responding well to an enzalutamide regimen may be able to stop treatment with an impact to their quality of life.
Mary B. Daly, MD, PhD, from Fox Chase Cancer Center, discusses the proper timing for screening patients with a family history of cancer.
Hawaii recently allowed medical aid in dying for patients with terminal diseases, and other states may soon follow suit.
Cathy Belt, RN, MSN, AOCN, Abramson Cancer Center of the University of Pennsylvania, discusses possible steps individuals can take upon finding out they have an inherited cancer syndrome, such as mutations in the BRCA1 or BRCA2 genes.
Stephanie Gilbertson-White, PhD, APRN-BC, assistant professor, University of Iowa College of Nursing, discusses a pilot study that evaluated performance status, quality of life and survival in patients with advanced cancer who were referred to palliative care.
What group of our patients is diagnosed with a devastating illness in early childhood which gets increasingly worse with age and leads to debilitating pain which is both chronic and acute in nature?
Optune, a noninvasive device that delivers tumor-treating fields to the brain, had been found to improve efficacy compared to chemotherapy and is well-tolerated by patients with glioblastoma multiforme (GBM).
Jennifer Wenzel, PhD, RN, CCN, FAAN, discusses the importance of including minority patients in clinical trials
Ahead of his presentation at the 39th Annual Miami Breast Cancer Conference, Charles L. Loprinzi, MD, highlights some non-estrogenic approaches to hot flash management for patients with breast cancer.
Laura Wood discusses the successful integration of avelumab, erdafitinib, and enfortumab vedotin-ejfv into oncology nursing practice.
Melisa Wong lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.
William Strauss, MD, Executive Director, Medical Affairs, AMAG Pharmaceuticals, Inc., discusses a study that analyzed mitigating oral mucositis symptoms in patients with head and neck cancers being treated with chemoradiation therapy.
Oncology nurses are crucial in the management of cancer symptoms and treatment-related adverse events.